Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Neoplasms × Caves × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cisplatin 9 pembrolizumab 7 Radiosurgery 6 Gemcitabine 6 Paclitaxel 5 Dexamethasone 5 Taxes 4 Carboplatin 4 trametinib 3 ibrutinib 3 Surveys and Questionnaires 3 Standard of Care 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Lenalidomide 3 Fluorouracil 3 Erlotinib Hydrochloride 3 Blood Specimen Collection 3 Ascorbic Acid 3 venetoclax 2 veliparib 2 tocilizumab 2 pazopanib 2 obinutuzumab 2 naquotinib 2 lenvatinib 2 fludarabine 2 enzalutamide 2 Vemurafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036045 2025-10-06

Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity

Connecticut Children's Medical Center

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡